Incyte Corporation (Nasdaq:INCY) announced that it has scheduled its third quarter 2011 financial results conference call for 8:30 a.m. ET on Thursday, October 27, 2011.

Incyte Corporation focuses on the discovery and development of proprietary small molecule drugs for hematologic and oncology indications, and inflammatory and autoimmune diseases.

******************************